Firms
Bain Capital Life Sciences
- Founded
- —
- Type
- Venture capital
Funds2
Bain Capital Life Sciences Fund IV$3B
Approximately USD 3 billion total commitments, including approximately USD 2.5 billion external commitments and the balance from Bain partners/employees/affiliates; September 10, 2024 Raised/closed fund. Latest-known BCLS fund found; no verified Fund V close found in newer-fund searches. [Official BCLS announcement](https://www.baincapitallifesciences.com/news/bain-capital-life-sciences-raises-fourth-fund); final close independently confirmed by fund counsel on [October 8, 2024](https://www.ropesgray.com/en/news-and-events/news/2024/10/bain-capital-life-sciences-raises-fourth-fund).
Bain Capital Life Sciences Fund IV—
Approximately USD 3 billion total commitments, approximately USD 2.5 billion external, balance partners/employees/affiliates. Closed; counsel confirmed final close October 8 publication. Approximate value preserved in description rather than exact monetary field.
Team
No team members on record yet.
Co-investing
CereVasc, Inc.$85M · 2026-06-04
CereVasc, Inc.$85M · 2026
Cerevasc$70M · 2024-05-13
CereVasc, Inc.$85M · 2026-06-04
CereVasc, Inc.$85M · 2026
CereVasc, Inc.$85M · 2026-06-04
CereVasc, Inc.$85M · 2026
Annexon Biosciences$75M · 2018-12-19
Annexon Biosciences$75M · 2018-12-19
Syremis Therapeutics$165M · 2025-12-18
GV
Syremis Therapeutics$165M · 2025-12-18
Annexon Biosciences$75M · 2018-12-19
Annexon Biosciences$75M · 2018-12-19
Syremis Therapeutics$165M · 2025-12-18
Syremis Therapeutics$165M · 2025-12-18
Annexon Biosciences$75M · 2018-12-19
Annexon Biosciences$75M · 2018-12-19
Syremis Therapeutics$165M · 2025-12-18